The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Health Catalyst Inc shares valued at $30,007 were sold by LeSueur Daniel on Feb 05 ’25. At $5.76 per share, LeSueur Daniel sold 5,209 shares. The insider’s holdings dropped to 86,044 shares worth approximately $0.48 million following the completion of this transaction.
Also, DANIEL LESUEUR purchased 5,209 shares, netting a total of over 29,275 in proceeds.
Before that, Llewelyn Linda had sold 6,442 shares from its account. In a trade valued at $37,348, the Chief People Officer traded Health Catalyst Inc shares for $5.80 each. Upon closing the transaction, the insider’s holdings decreased to 6,442 shares, worth approximately $0.51 million.
As published in a research note from KeyBanc Capital Markets on January 08, 2025, Health Catalyst Inc [HCAT] has been rated up from a Sector weight to an Overweight and the price target has been revised to $9. Analysts at KeyBanc Capital Markets downgraded the stock from ‘”an Overweight”‘ to ‘”a Sector weight”‘ outlook in a report released in early April. As of January 03, 2024, Evercore ISI has increased its “an In-line” rating to a “an Outperform” for HCAT. Earlier on January 03, 2024, Barclays initiated its rating. Their recommendation was “an Overweight” for HCAT stock.
Analyzing HCAT Stock Performance
During the last five days, there has been a surge of approximately 1.09%. Over the course of the year, Health Catalyst Inc shares have dropped approximately -21.50%. Shares of the company reached a 52-week high of $7.65 on 01/06/25 and a 52-week low of $5.32 on 02/03/25. A 50-day SMA is recorded $6.71, while a 200-day SMA reached $7.14. Nevertheless, trading volume fell to 0.57 million shares from 0.87 million shares the previous day.
Support And Resistance Levels for Health Catalyst Inc (HCAT)
According to the 24-hour chart, there is a support level at 5.45, which, if violated, would cause prices to drop to 5.36. In the upper region, resistance lies at 5.61. The next price resistance is at 5.68. RSI (Relative Strength Index) is 40.80 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.12, which suggests the price will decrease in the coming days. Percent R is at 61.69%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
